Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,262 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00002227

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Richard Elion Washington D.C., District of Columbia, United States
  • The Whitman Walker Clinic Washington D.C., District of Columbia, United States
  • Community Research Initiative of New England Brookline, Massachusetts, United States
  • Remington Davis Inc Columbus, Ohio, United States
View Trial Details
Completed

A Study to Compare Two Anti-HIV Drug Combinations

NCT00002447

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham / AIDS Outpatient Clinic Birmingham, Alabama, United States
  • St Mary's Med Ctr Long Beach, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
  • Kaiser Foundation Hospital San Francisco, California, United States
View all 26 locations
View Trial Details
Completed

A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy

NCT00002247

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations
  • East Bay AIDS Ctr Berkeley, California, United States
  • AIDS Clinical Research Ctr / UCLA Med Ctr Los Angeles, California, United States
  • UCSD Med Ctr / Pediatrics San Diego, California, United States
  • San Francisco Gen Hosp San Francisco, California, United States
View all 20 locations
View Trial Details
Completed

A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients

NCT00002218

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • ViRx Inc Palm Springs, California, United States
  • ViRx Inc San Francisco, California, United States
  • Central Florida Research Initiative Maitland, Florida, United States
  • Natl Institutes of Health Bethesda, Maryland, United States
View Trial Details
Completed

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

NCT00002299

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations
  • USC Los Angeles, California, United States
  • UCI Med Ctr Orange, California, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • Stanford at Kaiser / Kaiser Permanente Med Ctr San Francisco, California, United States
View Trial Details
Completed

A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

NCT00002399

Conditions
AIDS-Related Opportunistic Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +19 more
Locations
  • Tucson Veterans Administration Med Ctr Tucson, Arizona, United States
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Miami Veterans Administration Med Ctr Miami, Florida, United States
  • Mercy Hosp Miami, Florida, United States
View all 53 locations
View Trial Details

Related conditions